Cargando…

Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization

The discovery of drugs capable of inhibiting SARS-CoV-2 is a priority for human beings due to the severity of the global health pandemic caused by COVID-19. To this end, repurposing of FDA-approved drugs such as NSAIDs against COVID-19 can provide therapeutic alternatives that could be utilized as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abo Elmaaty, Ayman, Hamed, Mohammed I. A., Ismail, Muhammad I., B. Elkaeed, Eslam, S. Abulkhair, Hamada, Khattab, Muhammad, Al-Karmalawy, Ahmed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234583/ https://www.ncbi.nlm.nih.gov/pubmed/34205704 http://dx.doi.org/10.3390/molecules26123772

Ejemplares similares

Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study
por: Elmaaty, Ayman Abo, et al.
Publicado: (2021)

β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization
por: Hamed, Mohammed I. A., et al.
Publicado: (2021)

A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
por: Ashour, Nada A, et al.
Publicado: (2022)

Revisiting Activity of Some Nocodazole Analogues as a Potential Anticancer Drugs Using Molecular Docking and DFT Calculations
por: Khattab, Muhammad, et al.
Publicado: (2021)

Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
por: Elagawany, Mohamed, et al.
Publicado: (2022)

Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR(WT) and EGFR(T790M) inhibitors
por: Al-Warhi, Tarfah, et al.
Publicado: (2022)

Anticoagulants as Potential SARS-CoV-2 M(pro) Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
por: Abo Elmaaty, Ayman, et al.
Publicado: (2022)

Participation of cannabinoid receptors in peripheral nociception induced by some NSAIDs
por: Silva, L.C.R., et al.
Publicado: (2012)

In Silico Prediction of a Multitope Vaccine against Moraxella catarrhalis: Reverse Vaccinology and Immunoinformatics
por: Soltan, Mohamed A., et al.
Publicado: (2021)

Improved percutaneous delivery of some NSAIDs for the treatment of arthritis
por: Thosani, Rushabh, et al.
Publicado: (2012)

In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
por: Elmaaty, Ayman Abo, et al.
Publicado: (2021)

Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
por: Farouk, Faten, et al.
Publicado: (2023)

A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial
por: El-Haggar, Sahar M, et al.
Publicado: (2022)

Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies
por: Khalifa, Mohamed M., et al.
Publicado: (2021)

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis
por: Nawaz, Muhammad Haseeb, et al.
Publicado: (2020)

Gut Microbiota in NSAID Enteropathy: New Insights From Inside
por: Wang, Xianglu, et al.
Publicado: (2021)

Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity
por: Mourad, Mai A. E., et al.
Publicado: (2023)

Caution with NSAIDs
por: Crighton, A., et al.
Publicado: (2020)

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
por: Mahmoud, Amal, et al.
Publicado: (2021)

Review of the cardiovascular safety of COXIBs compared to NSAIDS
por: Moodley, I
Publicado: (2008)

Setting Health Priorities
por: Kerwin, Robert
Publicado: (1999)

Pain Management in Children: NSAID Use in the Perioperative and Emergency Department Settings
por: Cooney, Maureen F.
Publicado: (2021)

Priority setting: what constitutes success? A conceptual framework for successful priority setting
por: Sibbald, Shannon L, et al.
Publicado: (2009)

Priority setting for the introduction of rotavirus vaccine: what evidence was essential?
por: Glass, Roger I.
Publicado: (2018)

In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (M(pro))
por: Alesawy, Mohamed S., et al.
Publicado: (2021)

Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
por: Kutkat, Omnia, et al.
Publicado: (2022)

Editorial: NSAIDs Pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2021)

Priority-setting, the Indian way
por: Rao, Neethi V, et al.
Publicado: (2018)

The Canadian Frailty Priority Setting Partnership: Research Priorities for Older Adults Living with Frailty
por: Bethell, Jennifer, et al.
Publicado: (2019)

The unfunded priorities: an evaluation of priority setting for noncommunicable disease control in Uganda
por: Essue, Beverley M., et al.
Publicado: (2018)

Cardiorenal Effects of Newer NSAIDs (Celecoxib) versus Classic NSAIDs (Ibuprofen) in Patients with Arthritis
por: Hegazy, Ragia, et al.
Publicado: (2011)

Comparison of CD63 Upregulation Induced by NSAIDs on Basophils and Monocytes in Patients with NSAID Hypersensitivity
por: Abuaf, N., et al.
Publicado: (2012)

Influence of Cyclodextrin Complexation with NSAIDs on NSAID/Cold Stress-Induced Gastric Ulceration in Rats
por: Alsarra, Ibrahim A., et al.
Publicado: (2010)

Setting research priorities for management and treatment of hyperhidrosis: the results of the James Lind Alliance Priority Setting Partnership
por: Dunford, Louise Jane, et al.
Publicado: (2022)

COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
por: Russell, Beth, et al.
Publicado: (2020)

How is inclusiveness in health systems research priority-setting affected when community organizations lead the process?
por: Pratt, Bridget, et al.
Publicado: (2022)

Synthesis, Characterization, and Anti-Cancer Activity of Some New N′-(2-Oxoindolin-3-ylidene)-2-propylpentane hydrazide-hydrazones Derivatives
por: El-Faham, Ayman, et al.
Publicado: (2015)

A knock-out for NSAIDs.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_5e0j1mj4dkdud7tlom3m2apfs4